Welcome Message

Welcome to the 12th International Conference on Geriatric Cardiology, Cardiovascular Diseases, and Palliative Care
October 22-23, 2025 | Paris, France

It is with great pleasure that we welcome you to this pivotal gathering of healthcare professionals, researchers, and advocates dedicated to advancing the field of geriatric cardiology. Over the next two days, we come together with a shared commitment: to improve cardiovascular health and enhance the quality of life for older adults worldwide.

As we navigate one of the most profound demographic shifts of our time, the aging population presents both challenges and opportunities in cardiovascular care. This conference provides a vital platform to explore innovative solutions, share cutting-edge research, and foster meaningful collaborations that address these unique needs.

Our dynamic program includes keynote addresses from esteemed global experts, groundbreaking research presentations, interactive workshops, and opportunities to connect with peers from around the world. Whether you are a seasoned cardiologist, a geriatric care specialist, a researcher, or a healthcare policy advocate, your presence and insights are instrumental in shaping the future of geriatric cardiology.

As we engage in this collective journey of discovery and innovation, let us keep in mind the individuals who inspire our work—the older adults who rely on us for compassionate, evidence-based care. Their well-being remains at the heart of our mission, driving us to push the boundaries of what is possible.

We are honored by your participation in this momentous event and eagerly anticipate the ideas, inspiration, and progress that will emerge from our shared efforts.

Welcome, and together, let’s make a lasting impact.

Sessions & Tracks

Atherosclerotic cardiovascular disease (ASCVD)

Atherosclerotic cardiovascular disease (ASCVD) is a condition characterized by the buildup of plaque—composed of cholesterol, fatty substances, calcium, and fibrin—inside the arteries. This progressive narrowing and hardening of the arteries reduce blood flow, increasing the risk of heart attacks, strokes, and other cardiovascular complications.

Major risk factors for ASCVD include high cholesterol, hypertension, diabetes, smoking, obesity, sedentary lifestyle, and genetic predisposition. Chronic inflammation and oxidative stress also contribute to plaque formation and rupture, which can lead to life-threatening events.

Prevention and management involve lifestyle modifications such as a heart-healthy diet, regular exercise, smoking cessation, and stress management. Medications, including statins, antiplatelets, and antihypertensives, help control risk factors. In advanced cases, procedures like angioplasty or bypass surgery may be required.

Early detection through regular screenings and proactive management of risk factors significantly reduce the burden of ASCVD and improve long-term cardiovascular health.

Cardiomyopathies

Cardiomyopathies are diseases of the heart muscle that impair its ability to pump blood effectively. They include dilated, hypertrophic, restrictive, and arrhythmogenic types. Causes range from genetics and infections to chronic conditions like hypertension. Symptoms vary but may include fatigue, breathlessness, and arrhythmias. Treatment depends on type and severity.

Hyperlipidemia

Hyperlipidemia is a condition characterized by elevated levels of lipids (cholesterol and triglycerides) in the blood, increasing the risk of cardiovascular diseases such as atherosclerosis, heart attacks, and strokes. It is often caused by genetic factors, poor diet, obesity, sedentary lifestyle, and certain medical conditions like diabetes and hypothyroidism.

There are two main types: primary hyperlipidemia, which is inherited, and secondary hyperlipidemia, caused by lifestyle or underlying diseases. Diagnosis is made through lipid profile tests measuring LDL (bad cholesterol), HDL (good cholesterol), and triglycerides.

Management includes lifestyle changes (healthy diet, exercise, weight control) and medications like statins to lower lipid levels.

Acute coronary syndromes

Acute coronary syndromes (ACS) refer to a group of life-threatening conditions caused by reduced blood flow to the heart, typically due to plaque rupture and blood clot formation in the coronary arteries. ACS includes unstable angina, non-ST-elevation myocardial infarction (NSTEMI), and ST-elevation myocardial infarction (STEMI).

Symptoms include chest pain, shortness of breath, nausea, and sweating. Immediate diagnosis and treatment are critical to prevent heart damage. Management involves medications (antiplatelets, anticoagulants, beta-blockers, statins), lifestyle changes, and procedures like angioplasty or coronary artery bypass grafting (CABG). Early intervention significantly improves survival and long-term heart health.

Anticoagulation Management

Anticoagulation management involves the use of medications to prevent or treat blood clots, reducing the risk of stroke, deep vein thrombosis (DVT), pulmonary embolism (PE), and other thromboembolic conditions. Common anticoagulants include warfarin, heparin, low-molecular-weight heparins (LMWH), and direct oral anticoagulants (DOACs) like rivaroxaban and apixaban.

Effective management requires careful monitoring of blood clotting parameters, such as INR (for warfarin users), and adjusting doses to balance efficacy with bleeding risk. Patient education on diet, drug interactions, and adherence is crucial. In emergencies, reversal agents like vitamin K or specific antidotes may be required.

Arrhythmias and Clinical EP

Arrhythmias are abnormal heart rhythms caused by irregular electrical activity in the heart, leading to too fast (tachycardia), too slow (bradycardia), or erratic beats. They can result from structural heart disease, electrolyte imbalances, or genetic conditions. Symptoms range from palpitations and dizziness to life-threatening cardiac arrest.

Clinical Electrophysiology (EP) is a specialized cardiology field that diagnoses and treats arrhythmias using electrophysiological studies (EPS), catheter ablation, implantable devices (pacemakers, defibrillators), and antiarrhythmic medications. Early diagnosis and treatment are crucial in preventing complications like stroke and heart failure. Advances in EP improve arrhythmia management and patient outcomes.

Cardio-Oncology

Cardio-oncology is a specialized field that focuses on preventing, diagnosing, and managing cardiovascular complications in cancer patients and survivors. Cancer treatments such as chemotherapy, radiation, and targeted therapies can cause heart damage, leading to conditions like cardiomyopathy, heart failure, arrhythmias, and hypertension.

Cardio-oncologists work closely with oncologists to balance cancer treatment efficacy with cardiovascular risk management. Strategies include regular cardiac monitoring, early detection of cardiotoxicity, lifestyle modifications, and cardioprotective medications. The goal is to optimize heart health while ensuring effective cancer treatment, improving both survival rates and quality of life for cancer patients and survivors.

Chronic Angina

Chronic angina is a condition characterized by recurring chest pain or discomfort due to reduced blood flow to the heart, typically caused by coronary artery disease (CAD). It occurs when the heart muscle doesn’t receive enough oxygen, especially during physical exertion or stress.

Symptoms include chest tightness, pressure, or pain that may radiate to the arms, neck, jaw, or back. Management includes lifestyle changes, medications (nitrates, beta-blockers, calcium channel blockers), and procedures like angioplasty or coronary artery bypass grafting (CABG) if necessary. Proper treatment helps reduce symptoms, improve quality of life, and prevent complications like heart attacks.

Diabetes and Cardiometabolic Disease

Diabetes and cardiometabolic diseases are interrelated conditions that affect the heart, blood vessels, and metabolism. Type 1 and Type 2 diabetes are characterized by high blood sugar levels due to either insulin resistance or insufficient insulin production. Cardiometabolic diseases, which include hypertension, dyslipidemia, and obesity, increase the risk of heart disease, stroke, and kidney problems. The presence of diabetes significantly raises the likelihood of developing these cardiovascular conditions.

Risk factors include genetics, lifestyle choices (e.g., poor diet, physical inactivity), and obesity. Managing blood sugar levels, maintaining a healthy weight, and adopting a heart-healthy diet are essential for preventing complications. Treatment options often include medications, insulin therapy, and lifestyle modifications aimed at improving overall cardiovascular health and metabolic function. Regular monitoring is key to managing these chronic conditions and reducing long-term health risks.

Hypertriglyceridemia

Hypertriglyceridemia is a condition where there are high levels of triglycerides (a type of fat) in the blood. It is often linked to obesity, poor diet, uncontrolled diabetes, and excessive alcohol consumption. High triglycerides increase the risk of cardiovascular disease, including atherosclerosis and heart attack. Symptoms may not be apparent, but extremely high triglycerides can lead to pancreatitis. Management involves lifestyle changes such as dietary modifications, physical activity, and medications like statins or fibrates to lower triglyceride levels.

Invasive Cardiovascular Angiography and Intervention

Invasive cardiovascular angiography is a diagnostic procedure used to visualize the blood vessels of the heart and identify any blockages or abnormalities. A catheter is inserted into an artery (usually in the groin or wrist), and contrast dye is injected to make the blood vessels visible on X-ray. This technique is used to assess coronary artery disease and guide interventional procedures such as angioplasty, stenting, or coronary artery bypass surgery. It is critical in managing patients with acute coronary syndrome or severe heart disease.

Anticoagulation Management

Anticoagulation management refers to the use of blood thinners to prevent or treat conditions like deep vein thrombosis (DVT), pulmonary embolism (PE), and atrial fibrillation. Common anticoagulants include warfarin, heparin, and direct oral anticoagulants (DOACs). Proper management involves regular monitoring of blood clotting levels, adjusting doses to avoid complications such as bleeding or clot formation. The goal is to balance the risks of bleeding and clotting. Healthcare providers regularly assess patient medical history, kidney function, and comorbid conditions to determine the most appropriate anticoagulation therapy.

Noninvasive Imaging

Noninvasive imaging refers to diagnostic techniques used to visualize and assess heart conditions without requiring surgery or insertion of instruments. Methods include echocardiography, CT angiography, MRI, and nuclear imaging. These techniques help diagnose conditions such as coronary artery disease, heart failure, valvular heart disease, and cardiac function. Noninvasive imaging is crucial for monitoring heart health, guiding treatment decisions, and assessing disease progression, all while minimizing patient discomfort and risk.

Pericardial Disease

Pericardial disease refers to conditions affecting the pericardium, the protective sac surrounding the heart. It includes pericarditis (inflammation of the pericardium), pericardial effusion (fluid accumulation), and cardiac tamponade (pressure on the heart due to excess fluid). Symptoms may include chest pain, shortness of breath, and fatigue. Pericardial disease can result from infections, autoimmune diseases, cancer, or post-heart surgery complications. Treatment typically involves anti-inflammatory medications, drainage of fluid in severe cases, or surgery in cases of chronic effusion or tamponade.

Pulmonary Hypertension and Venous Thromboembolism

Pulmonary hypertension (PH) is a condition where there is high blood pressure in the arteries of the lungs, leading to heart failure and other complications. Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE), is the formation of blood clots that travel to the lungs and obstruct pulmonary arteries, potentially leading to PH. Both conditions often share risk factors such as chronic diseases, immobility, and obesity. Treatment may involve anticoagulation therapy, vasodilators, oxygen therapy, and in some cases, surgical intervention.

Sports and Exercise Cardiology

Sports and exercise cardiology focuses on the heart health of athletes and active individuals, assessing the impact of exercise on cardiovascular function. It includes preventive screenings, diagnosis of exercise-related cardiovascular conditions, and management of heart conditions in athletes. Common issues addressed include arrhythmias, hypertrophic cardiomyopathy, and exercise-induced ischemia. This field emphasizes the balance between optimal performance and cardiovascular safety, with guidelines for safe exercise in athletes and individuals with known cardiovascular disease.

Vascular Medicine

Vascular medicine deals with the diagnosis and treatment of diseases affecting the blood vessels, including arteries, veins, and lymphatics. Conditions like peripheral artery disease (PAD), varicose veins, venous insufficiency, and aneurysms are managed in this specialty. Vascular medicine emphasizes non-invasive diagnostic tools (e.g., ultrasound) and interventional procedures (e.g., angioplasty, stenting, and surgery) to restore blood flow and prevent complications such as stroke and limb loss. Risk factors include smoking, diabetes, hypertension, and obesity. Treatment often involves lifestyle changes, medications, and minimally invasive surgical options.

Aortic Stenosis

Aortic stenosis is a condition where the aortic valve of the heart becomes narrowed, restricting blood flow from the heart to the rest of the body. This can lead to heart failure, chest pain, fainting, and shortness of breath. The most common cause is age-related calcification, but it can also result from congenital valve defects or rheumatic fever. Treatment often involves surgical valve replacement or transcatheter aortic valve replacement (TAVR), depending on the severity and the patient’s overall health.

Senile Cardiac Amyloidosis

Senile cardiac amyloidosis is a condition where amyloid proteins accumulate in the heart tissue, affecting its ability to contract and relax properly. This condition is most common in the elderly and is caused by wild-type transthyretin amyloidosis. Symptoms include heart failure, arrhythmias, and fatigue. Diagnosis is often made with cardiac imaging and biopsy. Treatment focuses on symptom management, including diuretics and medications to control heart rate, with emerging therapies targeting amyloid deposits.

Heart Rhythm and Arrhythmias

Heart rhythm disorders, or arrhythmias, occur when the heart’s electrical system malfunctions, leading to an irregular heartbeat. Common arrhythmias include atrial fibrillation, ventricular tachycardia, and bradycardia. These conditions can cause palpitations, dizziness, fainting, or stroke. Treatment options include antiarrhythmic medications, cardioversion, catheter ablation, and implantable devices like pacemakers or defibrillators. Managing risk factors such as high blood pressure and diabetes is crucial in preventing arrhythmias.

HIV and Heart Disease

People with HIV are at an increased risk of developing heart disease due to chronic inflammation, antiretroviral therapies (which may have cardiovascular side effects), and traditional risk factors such as smoking and diabetes. The most common cardiovascular complications include coronary artery disease, stroke, and heart failure. Prevention and management involve early HIV treatment, lifestyle modifications (such as healthy diet and exercise), and cardiovascular medications. Regular screening for heart disease is important in HIV-positive individuals, especially with longer life expectancies due to improved treatments.

Interventional Cardiology

Interventional cardiology is a specialized field focused on using catheters and other minimally invasive techniques to diagnose and treat heart conditions. Procedures include angioplasty, stenting, and valve repair. Interventional cardiologists treat conditions like coronary artery disease, heart attacks, and structural heart diseases. These procedures are often done without the need for open-heart surgery, allowing for faster recovery and reduced risk. Advancements in robotic-assisted techniques and intracoronary imaging have enhanced the precision and success rates of these interventions.

Myocardial Biology and Heart Failure

Myocardial biology refers to the study of the heart muscle (myocardium) and its function in both health and disease. In heart failure, the heart cannot pump blood efficiently, leading to fluid buildup and organ dysfunction. The biological mechanisms include cellular injury, fibrosis, and impaired contractility. Research in this field is focused on regenerative therapies, gene therapy, and stem cell approaches to restore heart function. Treatments aim to manage symptoms, prevent disease progression, and improve quality of life, often involving medications, devices, or heart transplants in advanced cases.

Leading Discovery and Innovation in Cardiac Surgery

Cardiac surgery is at the forefront of medical innovation, with continuous advancements in minimally invasive techniques, robotic surgery, and biomaterials. Modern approaches such as transcatheter valve replacement, robot-assisted coronary artery bypass grafting (CABG), and heart transplantations have significantly improved patient outcomes. Innovation is also leading to the development of novel prosthetic valves, genetic therapies, and personalized medicine for heart surgery. Researchers and surgeons are constantly exploring ways to enhance recovery, reduce complications, and improve long-term heart health.

Preventive Cardiology

Preventive cardiology focuses on reducing the risk of heart disease before it occurs. It involves screening for risk factors such as high blood pressure, high cholesterol, smoking, obesity, and family history. Prevention strategies include lifestyle modifications like regular physical activity, healthy eating, stress management, and medications to control risk factors. Early intervention can significantly reduce the likelihood of developing cardiovascular conditions like heart attack, stroke, and heart failure. Preventive cardiology aims to improve overall health outcomes and quality of life by addressing risk factors early.

Stem Cell and Regenerative Biology

Stem cell and regenerative biology focus on using stem cells to repair or replace damaged heart tissue. Cardiac stem cell therapy aims to regenerate the heart after damage from conditions like heart attacks or heart failure. Research is ongoing into cellular reprogramming, bioengineering, and gene therapy to enhance the heart’s natural healing ability. These innovative therapies offer potential solutions to restoring heart function, improving survival rates, and reducing the need for transplants or long-term reliance on heart devices.

Women and Heart Disease

Heart disease in women presents differently than in men and is often under-recognized. Risk factors such as pregnancy complications, menopause, and hormonal imbalances increase the risk for cardiovascular diseases in women. Symptoms can be more subtle, such as nausea, fatigue, and shortness of breath, rather than the classic chest pain. Women also face higher rates of heart disease after menopause. Preventive care involves regular screenings, lifestyle changes, and early management of risk factors. Cardiologists are focusing on improving the understanding of gender differences in heart disease to provide tailored treatments for women.

Palliative Care Across Specialties

Oncology and Geriatrics
Palliative care in oncology focuses on alleviating symptoms, enhancing quality of life, and addressing the emotional and psychosocial challenges faced by cancer patients. In geriatrics, it aims to meet the unique needs of older adults, balancing chronic disease management with comfort-focused interventions.

Cardiology, Pediatrics, and Neurology
In cardiology, palliative care supports patients with advanced heart diseases, offering relief from symptoms like breathlessness and fatigue while addressing end-of-life planning. Pediatric palliative care provides holistic support for children with life-limiting conditions and their families. In neurology, it plays a crucial role in managing conditions like ALS, Parkinson's, and advanced dementia, ensuring dignity and comfort.

Critical Care and Specialized Areas
Critical care palliative services integrate symptom management with decision-making support for critically ill patients. Hematology, pulmonology, nephrology, and gastroenterology utilize palliative care to address the complexities of organ-specific diseases, from managing anemia and respiratory distress to alleviating renal failure symptoms and gastrointestinal discomfort, ensuring patient-centered care across all stages of illness.

Geroscience and Cardiovascular Health: Emerging studies emphasize the role of geroscience, which targets the biological mechanisms of aging, such as cellular senescence and mitochondrial dysfunction. These interventions aim to prevent or delay the onset of age-related CVD and associated frailty. 

Percutaneous Coronary Interventions (PCI) and Surgery: For older adults, PCI continues to be a vital treatment for acute coronary syndromes, showing lower in-hospital mortality rates compared to medical therapy. However, research also indicates that in high-risk cases, coronary artery bypass grafting (CABG) may offer better long-term outcomes. 

Tailoring Treatments to Age and Frailty: Research highlights the complexities of managing polypharmacy, bleeding risks, and cognitive concerns in elderly patients undergoing cardiovascular procedures. 

The Impact of Kinlessness on Older Adults with Advanced Heart Failure

Recent studies highlight the significant challenges faced by older adults with advanced heart failure (HF) who lack traditional kin networks (spouses or children). Kinlessness, a growing phenomenon, has been linked to poorer access to advanced treatments like left ventricular assist devices (LVADs) or heart transplants. Social isolation also correlates with higher rates of institutionalization and unmet care needs. Research underscores disparities in care: kinless patients are often under-referred for advanced therapies and face barriers in end-of-life care, with fewer dying in hospice settings compared to those with kin. These findings stress the need for targeted social support interventions to address these inequities

Revascularization in Frail Patients With Acute Coronary Syndrome (ACS)

Recent studies highlight the importance of tailoring treatment strategies for frail patients presenting with ACS. Revascularization, involving percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG), has shown both short- and long-term cardiovascular (CV) benefits in this population.

AF Screening With a 14-Day ECG Monitor

Recent studies highlight the use of 14-day ECG monitoring for atrial fibrillation (AF) screening in older adults. One such trial, the GUARD-AF study, focused on individuals aged 70 and older without prior AF diagnosis. The use of a continuous patch-based ECG monitor significantly increased AF detection rates by over 50% compared to usual care. 

Cardiometabolic Health:

Cardiometabolic health encompasses the interplay between cardiovascular diseases (CVDs) and metabolic disorders, including diabetes, obesity, hypertension, and dyslipidemia. This multifaceted domain addresses the underlying mechanisms linking metabolic imbalances to cardiovascular outcomes, emphasizing prevention, early detection, and personalized treatment strategies.

Clinical Implications

Effective management requires a multidimensional approach. Weight reduction, dietary improvements like the adoption of the Mediterranean or DASH diets, regular exercise, and smoking cessation play pivotal roles in mitigating risk. Pharmacological interventions, including statins, GLP-1 receptor agonists, and SGLT2 inhibitors, have proven effective in managing dyslipidemia, hyperglycemia, and heart failure risks.

Global Burden and Innovations
Cardiometabolic disorders are leading causes of morbidity and mortality worldwide, significantly straining healthcare systems. Innovations in digital health tools, such as wearable technologies and telemedicine, enable continuous monitoring and personalized feedback, improving patient adherence to therapeutic goals.

Cardio-oncology: Bridging Cancer Care and Cardiovascular Health

Cardio-oncology is an emerging medical field that focuses on the intersection of cardiovascular disease and cancer, particularly the cardiovascular effects of cancer treatments. Cancer therapies, such as chemotherapy, radiation, and targeted therapies, can cause significant damage to the heart and vasculature, leading to complications like cardiomyopathy, heart failure, arrhythmias, and vascular disease. The growing number of cancer survivors highlights the importance of monitoring and managing long-term cardiovascular risks in these patients.

Cerebrovascular Disease & Stroke

Cerebrovascular disease refers to a range of conditions that affect the blood vessels in the brain, leading to stroke and transient ischemic attacks (TIAs). Stroke remains a leading cause of disability and death worldwide, often caused by either a blockage (ischemic stroke) or bleeding (hemorrhagic stroke). Advances in prevention, such as lifestyle modifications and medical interventions, as well as improvements in acute stroke care, have contributed to better outcomes for many patients. 

Critical Care & Resuscitation
Critical care and resuscitation focus on the immediate treatment of patients with life-threatening conditions, such as cardiac arrest, severe trauma, and organ failure. In cardiovascular settings, resuscitation techniques, including CPR and defibrillation, are vital for saving lives. Advances in this area include improved protocols for post-cardiac arrest care, such as therapeutic hypothermia, and innovations in mechanical circulatory support devices. 

Congenital heart disease (CHD) refers to structural abnormalities of the heart that are present at birth. It can involve defects in the heart walls, valves, or blood vessels. Advances in early detection, prenatal screening, and surgical interventions have greatly improved survival rates for children born with CHD. Many individuals with CHD live into adulthood, requiring ongoing management for complications, such as arrhythmias and heart failure. The field continues to evolve with innovations in minimally invasive procedures, genetic testing, and lifelong care strategies

Gene & Tissue Regeneration

Genetics, omics, and tissue regeneration in cardiology represent cutting-edge areas of research aimed at understanding the genetic basis of cardiovascular diseases and using technology to repair or regenerate damaged tissues. Genomic studies are uncovering genetic mutations linked to heart disease, offering new avenues for personalized medicine. Advances in stem cell therapy and tissue engineering hold promise for repairing heart tissue damaged by infarction or other cardiovascular conditions. Omics technologies, including genomics, proteomics, and metabolomics, provide comprehensive insights into disease mechanisms, offering new targets for treatment .

Health Promotitive Cardiology
Health promotion and preventive cardiology focus on strategies to prevent cardiovascular diseases before they develop, rather than treating them once they occur. Lifestyle interventions, including diet, physical activity, and smoking cessation, play a critical role in reducing risk factors such as obesity, hypertension, and diabetes. Screening programs for early detection of risk factors, along with patient education, are central to preventive cardiology. Public health initiatives also promote the importance of cardiovascular health in all age groups, aiming to reduce the global burden of heart disease.

Heart Failure

Heart failure (HF) occurs when the heart cannot pump sufficient blood to meet the body's needs. Cardiomyopathies, diseases of the heart muscle, are a leading cause of heart failure. Treatment approaches for heart failure include medications, lifestyle changes, device therapy, and, in some cases, heart transplantation. Advances in pharmacotherapy, such as SGLT2 inhibitors and ARNI medications, have improved outcomes for heart failure patients. 

Hypertension : Blood pressure, is a major risk factor for cardiovascular diseases, including stroke, heart failure, and kidney disease. Effective management of hypertension is essential to prevent these complications. Strategies include lifestyle modifications, such as weight loss, reduced salt intake, and regular exercise, along with pharmacological treatments like ACE inhibitors, calcium channel blockers, and diuretics. 

Techniques such as echocardiography, MRI, CT scans, and nuclear imaging allow for detailed visualization of the heart and blood vessels. These methods are essential for assessing conditions like coronary artery disease, heart failure, valve abnormalities, and congenital heart defects. Recent advancements in imaging technologies, including 3D imaging and artificial intelligence, are enhancing diagnostic accuracy, enabling earlier detection, and improving treatment planning.

Ischemic Heart Disease
(IHD), also known as coronary artery disease, occurs when the heart's blood supply is restricted due to the narrowing of coronary arteries. It is the leading cause of heart attacks and sudden cardiac death. Treatment includes lifestyle modifications, medications like statins and antiplatelets, and procedures such as angioplasty and coronary artery bypass surgery. Research is focused on improving early detection through biomarkers, developing new therapies to restore blood flow, and reducing the risk of recurrent cardiovascular events.

Valvular Heart Disease

Valvular refers to disorders affecting the heart's valves, including stenosis (narrowing) and regurgitation (leakage). These conditions can lead to heart failure and other complications if untreated. Treatment includes medication, lifestyle management, and surgery, including valve repair or replacement. The advent of transcatheter valve interventions has revolutionized the treatment of valvular heart disease, particularly in high-risk patients who may not be candidates for traditional surgery. Research continues to explore innovative valve therapies and outcomes for patients with these conditions.

Market Analysis

The global geriatric cardiology and cardiovascular diseases market is experiencing significant growth due to increasing aging populations, a higher prevalence of chronic diseases, and advancements in medical technology.

1. Geriatric Cardiology
   • Global Trends: The geriatric population (aged 65 and older) is projected to double by 2050, with cardiovascular diseases (CVD) remaining a leading cause of morbidity and mortality.
   • Market Drivers: Rising demand for specialized geriatric care, personalized medicine, and minimally invasive cardiovascular procedures.
2. Cardiovascular Diseases (CVD)
   • Market Size: Estimated to surpass $550 billion by 2030.
   • Key Areas: Heart failure management, arrhythmias, coronary artery disease, and advanced diagnostics using AI-powered imaging technologies.
3. Palliative Care
   • Global Demand: Increasing focus on improving the quality of life for patients with terminal CVD conditions.
   • Growth Areas: Integration of palliative care into cardiovascular management plans, especially in aging societies.
4. Regional Insights
   • North America: Dominates due to advanced healthcare infrastructure and high healthcare expenditure.
   • Europe: Significant growth driven by aging populations and governmental focus on chronic disease management.
   • Asia-Pacific: Rapid market expansion due to urbanization, lifestyle changes, and improved healthcare access.
5. Challenges
   • Workforce shortages in geriatrics and palliative care.
   • Economic barriers to accessing advanced treatments in low-income regions.
6. Future Outlook
   • Emphasis on early diagnosis and prevention through telemedicine, wearable devices, and remote patient monitoring.
   • Collaborative research and innovation in treatment strategies for aging populations

Here is a combination of a pie chart and a bar chart:

1. Pie Chart: Displays the approximate market share for North America, Europe, and Asia-Pacific in the Geriatric Cardiology and Cardiovascular Diseases market.
2. Bar Chart: Shows the projected growth of the cardiovascular market from 2020 to 2030.
   
   

Why Attend?

• Gain insights from distinguished keynote speakers and experts in geriatric cardiology and palliative care.
• Discover cutting-edge research on cardiovascular diseases and treatment advancements.
• Engage in interactive panel discussions on the challenges and future directions of cardiovascular care.
• Participate in specialized workshops focusing on innovations in cardiac care and palliative approaches.
• Expand your professional network by connecting with leading healthcare professionals, researchers, and policymakers.

Who Should Attend?

• Cardiologists, geriatricians, and internal medicine specialists
• Researchers and academics in cardiovascular medicine
• Healthcare professionals involved in palliative and elderly care
• Clinical practitioners and hospital administrators
• Pharmaceutical and medical technology professionals
• Students and early-career researchers interested in cardiovascular health